J Dent Res:天然牙的CAD/CAM瓷修复材料

2018-07-19 lishiting MedSci原创

随着计算机辅助设计(CAD)和计算机辅助制作(CAM)技术的不断进步以及它们应用的便捷,促使这种全新的治疗理念在现代口腔修复学得以快速发展。固定口腔修复从传统治疗方法到近来微创治疗方法的变更证明了粘合CAD/CAM玻璃-陶瓷修复体临床应用的长期成功。

随着计算机辅助设计(CAD)和计算机辅助制作(CAM)技术的不断进步以及它们应用的便捷,促使这种全新的治疗理念在现代口腔修复学得以快速发展。固定口腔修复从传统治疗方法到近来微创治疗方法的变更证明了粘合CAD/CAM玻璃-陶瓷修复体临床应用的长期成功。

现如今,缺损定向修复,例如:嵌体、高嵌体和后牙冠主要是由单体玻璃陶瓷烧结制成。而各色各样的CAD/CAM瓷修复系统也在不断的革新以满足日益增加的需求,如:高美容、生物相容性和长效的修复效果。近年来,聚合物渗透的CAD/CAM网络结构瓷块为椅旁CAD/CAM 1次法修复提供了一种全新的选择。并且,材料特异性的高边缘稳固为CAD/CAM超薄修复边缘的可加工性提供基础。全轮廓氧化锆修复体以双层系统的模式不断获得市场份额。而材料科学与粘接方法的提升促使全新的材料结合或构建技术不断进展以保证高强度的氧化锆陶瓷。CAD/CAM的应用提供了一种标准化的制作程序,为单独或复杂的牙支持式修复创造一种可靠的、可预料的和经济的工作流程。

然而,还需要更多长期的临床研究来验证单体聚合物渗透的陶瓷网络结构和氧化锆牙支持式的微创和广泛修复的治疗效果。

原始出处:

Spitznagel FA, Boldt J, et al. CAD/CAM Ceramic Restorative Materials for Natural Teeth. J Dent Res. 2018 Jun 1:22034518779759. doi: 10.1177/0022034518779759.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1675327, encodeId=b29716e5327da, content=<a href='/topic/show?id=cb8a400091' target=_blank style='color:#2F92EE;'>#CAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4000, encryptionId=cb8a400091, topicName=CAM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ac27217804, createdName=whmdzju, createdTime=Mon Feb 18 00:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332769, encodeId=ad5e332e6958, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Jul 19 19:26:50 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332757, encodeId=e018332e5725, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Jul 19 18:28:18 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332742, encodeId=0edf332e4234, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/30/21f1f0d02514796066d52523c747be51.jpg, createdBy=75a31960463, createdName=zdvfsadb, createdTime=Thu Jul 19 17:15:43 CST 2018, time=2018-07-19, status=1, ipAttribution=)]
    2019-02-18 whmdzju
  2. [GetPortalCommentsPageByObjectIdResponse(id=1675327, encodeId=b29716e5327da, content=<a href='/topic/show?id=cb8a400091' target=_blank style='color:#2F92EE;'>#CAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4000, encryptionId=cb8a400091, topicName=CAM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ac27217804, createdName=whmdzju, createdTime=Mon Feb 18 00:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332769, encodeId=ad5e332e6958, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Jul 19 19:26:50 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332757, encodeId=e018332e5725, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Jul 19 18:28:18 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332742, encodeId=0edf332e4234, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/30/21f1f0d02514796066d52523c747be51.jpg, createdBy=75a31960463, createdName=zdvfsadb, createdTime=Thu Jul 19 17:15:43 CST 2018, time=2018-07-19, status=1, ipAttribution=)]
    2018-07-19 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1675327, encodeId=b29716e5327da, content=<a href='/topic/show?id=cb8a400091' target=_blank style='color:#2F92EE;'>#CAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4000, encryptionId=cb8a400091, topicName=CAM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ac27217804, createdName=whmdzju, createdTime=Mon Feb 18 00:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332769, encodeId=ad5e332e6958, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Jul 19 19:26:50 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332757, encodeId=e018332e5725, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Jul 19 18:28:18 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332742, encodeId=0edf332e4234, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/30/21f1f0d02514796066d52523c747be51.jpg, createdBy=75a31960463, createdName=zdvfsadb, createdTime=Thu Jul 19 17:15:43 CST 2018, time=2018-07-19, status=1, ipAttribution=)]
    2018-07-19 医者仁心5538

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1675327, encodeId=b29716e5327da, content=<a href='/topic/show?id=cb8a400091' target=_blank style='color:#2F92EE;'>#CAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4000, encryptionId=cb8a400091, topicName=CAM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ac27217804, createdName=whmdzju, createdTime=Mon Feb 18 00:42:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332769, encodeId=ad5e332e6958, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Jul 19 19:26:50 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332757, encodeId=e018332e5725, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Jul 19 18:28:18 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332742, encodeId=0edf332e4234, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/30/21f1f0d02514796066d52523c747be51.jpg, createdBy=75a31960463, createdName=zdvfsadb, createdTime=Thu Jul 19 17:15:43 CST 2018, time=2018-07-19, status=1, ipAttribution=)]
    2018-07-19 zdvfsadb

    学习了

    0

相关资讯

Clin oral invest:聚合物渗透陶瓷CAD/CAM嵌体和部分冠修复

这项5年来的前瞻性临床研究的目的是评估单片计算机辅助设计和计算机辅助制造(CAD / CAM)制作的微创渗透聚合物陶瓷网络(PICN)嵌体和部分冠(PCR)的长期效果。